Titel: Neurotechnology Meets Artificial Intelligence
Termin:
8.5.2019
Veranstaltungsort:
Referenten: Sabine Maasen (TU Munich) *** Gernot Müller-Putz (Graz University of Technology) *** Marc Hassenzahl (University of Siegen) *** Philipp Kellmeyer (University of Freiburg) *** Pim Haselager (Radboud University Nijmegen) *** Fiorella Battaglia (LMU Munich) *** Arne Manzeschke (Evangelische Hochschule Nürnberg – University of Applied Science) *** Michael Nagenborg (University of Twente) *** Vinzent Müller (University of Leeds) *** Etienne Roesch (University of Reading) *** Anders Sandberg (University of Oxford) *** Frederic Gilbert (University of Tasmania) *** Marcello Ienca (ETH Zurich) *** Jean-Marc Rickli (Geneva Center for Security Policy) *** Laurie Pycroft (University of Oxford) *** Stephan Sellmaier (LMU Munich) *** Sebastian Drosselmeier (LMU Munich) *** Anna Wilks (Acadia University) *** Georg Starke (University of Basel) *** Tom Buller (Illinois State University) *** Susanne Beck (University of Hannover) *** Argyro Karanasiou (University of Bournemouth) *** Stephen Rainey (University of Oxford) *** Kevin McGillivray (University of Norway) *** Tyr Fothergill (De Montfort University) *** Hannah Maslen (University of Oxford) *** Bernd Stahl (De Montfort University) *** Christoph Bublitz (University of Hambug) *** Mathias Vukelic (University of Stuttgart) *** Eric Racine (University of Montréal) *** Matthew Sample (University of Montréal) *** Christopher Coenen (University of Karlsruhe) *** Ralf J. Jox (Universität Lausanne) *** Steffen Steinert (TU Delft) *** Stephen Rainey (University of Oxford) *** Johannes Kögel (LMU Munich) *** Jennifer Schmid (LMU Munich)
Weitere Informationen:
https://neurotechmeetsai.wordpress.com/
Neurotechnologies such as brain-computer interfaces (BCIs) are no longer a futuristic dream or, depending on the viewpoint, a nightmare. They are subject of many research projects and their usability improves rapidly. Today, BCIs represent an important tool for a wide range of medical applications. For instance, they enable otherwise disabled patients to communicate by using a computer via brain activity. Beyond the medical context, they are used in the entertainment sector and developed for business applications. Moreover, it appears that with a similar technological apparatus of a brain-to-brain interface, a human brain can also be coupled with another human brain in order to transfer brain activity from one brain to cause brain activity in the other brain, e.g. to stimulate a movement.
At the same time, BCIs and other neurotechnologies stand in a relation with another emerging technology that cuts across many domains of technology use, i.e. Artificial Intelligence (AI). AI itself raises a host of original problems that can most aptly be summarized as “black box”-problems: It becomes increasingly difficult to supervise and control an AI’s operation because it manages its decision-making logic itself.
Moreover, the use of neurotechnologies and AI in combination elicits some further pressing philosophical, ethical, social and legal concerns, e.g.:
• How can we conceptualize agency, moral and legal responsibility and autonomy in intelligent neurotechnologies?
• What implications do BCIs and, even more so, BTBIs have for the concept of acting together?
• What consequences result in terms of mental privacy?
• Where is the normative borderline between curing illness, addressing disability and human enhancement, and what does it imply?
• What anthropological implications do neurotechnologies have?
• Are there particular legal or normative worries regarding the medical use of neurotechnologies?
• What are potential domains of application beyond medicine, e.g. the military? What are the ethical, legal and social implications in these contexts?
• What broader social implications result from the use of neurotechnologies in general?
The conference brings together a wide range of scholars with various disciplinary backgrounds (philosophy, law, social science, cognitive sciences, medicine) to discuss the multi-dimensional implications of neurotechnology and AI.
Kontakt:
Andreas Wolkenstein
andreas.wolkenstein@med.uni-muenchen.de
Veranstalter: The event takes place from May 8-10, 2019 in Munich (Germany). It is organized by the project INTERFACES at the Institute for Ethics, History and Medicine at the Ludwig-Maximilians-Universität (LMU) Munich. Project partners are located in Hamburg, Granada and Montreal. The project is funded by the Federal Ministry of Education and Research, as part of the ERANET Neuron program.